Literature DB >> 3465026

Protective properties of colloidal bismuth subcitrate on gastric mucosa.

D W Hall, W E van den Hoven.   

Abstract

Colloidal bismuth subcitrate (CBS), PGE2, sucralfate, and cimetidine have been investigated for their mucosal protective effects in the ethanol-induced gastric erosion model in rats; moreover, to gain an insight into the mechanisms of action of CBS, its ability to stimulate the synthesis of gastric mucosal PGE2 was determined. Although less potent than PGE2 at inhibiting ethanol-induced gastric lesions, CBS was about 4 times more potent than sucralfate. Cimetidine displayed only very weak protective activities. CBS showed a time-dependent inhibition of ethanol-induced lesions. Complete protection was observed 15 min after treatment with CBS and partial protection was observed at 8 h, although no protection was found at 16 h. CBS increased the potential of rat gastric mucosa to synthesize PGE2 in a dose-dependent way. Up to 3-fold increases above the basal levels were found. Peak synthesis of PGE2 occurred 15 min after CBS and elevated levels were still found after 4 h. It is concluded from these studies that CBS produces potent gastric protection towards ethanol-induced injury in the rat. CBS also considerably increases the ability of rat gastric mucosa to synthesize PGE2 which may be an underlying biochemical mechanism for its protective properties on the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3465026     DOI: 10.3109/00365528609102579

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  8 in total

1.  Effect of repeated colloidal bismuth subcitrate treatment on the response of the rat gastric mucosa to the presence of luminal ethanol.

Authors:  S M Hinsull; D Bellamy
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

2.  Mechanism of action of nonantisecretory agents.

Authors:  J De Wal
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

3.  Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques.

Authors:  P E O'Brien; G Frydman; R Holmes; C Malcontenti; D Phelan
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 4.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

5.  Eicosanoid synthesis in duodenal ulcer disease: decrease in leukotriene C4 by colloidal bismuth subcitrate.

Authors:  A Ahmed; P R Salmon; C R Cairns; M Hobsley; J R Hoult
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

6.  Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity.

Authors:  G S Sandha; R LeBlanc; S J Van Zanten; T D Sitland; L Agocs; N Burford; L Best; D Mahoney; P Hoffman; D J Leddin
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

7.  Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment.

Authors:  E Eleftheriadis; K Kotzampassi; E Tzartinoglou; A Salem; H Aletras
Journal:  Gastroenterol Jpn       Date:  1991-06

8.  Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus.

Authors:  D J Muñoz; C Tasman-Jones; J Pybus
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.